Results 31 to 40 of about 19,210 (233)

Relationship Between Scleral Thickness and Choroidal Structure in Central Serous Chorioretinopathy

Investigative Ophthalmology and Visual Science, 2023
Purpose Central serous chorioretinopathy (CSC) is a retinal disorder characterized by serous retinal detachment with or without pigment epithelial detachment in the posterior pole of the eye.
Naoya Imanaga, N. Terao, S. Sonoda, Shota Sawaguchi, Y. Yamauchi, T. Sakamoto, H. Koizumi   +6 more
semanticscholar   +1 more source

Risk of Central Serous Chorioretinopathy in Male Androgen Abusers

Ophthalmology and Therapy, 2023
Introduction Male gender is an important risk factor of central serous chorioretinopathy (CSC), and studies have explored the pathophysiological role of androgens in CSC with conflicting results.
Y. Subhi, Josefine Windfeld-Mathiasen, A. Horwitz, H. Horwitz   +3 more
semanticscholar   +1 more source

FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY [PDF]

Retina, 2019
Purpose: To assess ophthalmologic characteristics in patients and unaffected individuals in families with multiple members affected by central serous chorioretinopathy (CSC), both at presentation and long-term follow-up. Methods: In 103 subjects from 23 families with at least 2 ...
van Dijk, E.H.C., Schellevis, R.L., Breukink, M.B., Mohabati, D., Dijkman, G., Keunen, J.E., Yzer, S., den Hollander, A.I., den Hollander, A.I., Hoyng, C.B., de Jong, E.K., Boon, C.J.F.   +11 more
openaire   +4 more sources

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities

Acta ophthalmologica, 2022
The pachychoroid disease spectrum (PDS) includes several chorioretinal diseases that share specific choroidal abnormalities. Although their pathophysiological basis is poorly understood, diseases that are part of the PDS have been hypothesized to be the ...
J. Brinks, E. V. van Dijk, O. Meijer, R. Schlingemann, C. Boon   +4 more
semanticscholar   +1 more source

The differential diagnosis of central serous chorioretinopathy and other diseases associated with subretinal fluid in the macula.

Progress in retinal and eye research, 2021
A wide range of ocular diseases can present with serous subretinal fluid in the macula and therefore clinically mimic central serous chorioretinopathy (CSC).
E. V. van Dijk, C. Boon
semanticscholar   +1 more source

Central serous chorioretinopathy

Indian Journal of Ophthalmology, 1977
Badrinath S, Baig S
doaj   +2 more sources

Wide Field Choroidal Thickness of Eyes with Central Serous Chorioretinopathy Examined by Swept-Source Optical Coherence Tomography.

Ophthalmology Retina, 2022
PURPOSE To examine widefield (WF) changes in the choroidal thickness of eyes with central serous chorioretinopathy (CSC). DESIGN An observational study.
M. Ishikura, Yuki Muraoka, Naomi Nishigori, Ayako Takahashi, M. Miyake, Naoko Ueda-Arakawa, Manabu Miyata, S. Ooto, A. Tsujikawa   +8 more
semanticscholar   +1 more source

Etiopathogenetical approaches to the diagnosis and treatment of acute and chronic central serous chorioretinopathy. Review

Oftalʹmologiâ, 2014
Central serous chorioretinopathy is still considered a disease with uncomletely studied etiology and pathogenesis, so there is no single approach to the treatment of this condition. In review the known factors of central serous chorioretinopathy, as well
A. G. Shchuko, A. N. Zlobina, T. N. Iureva   +2 more
doaj   +3 more sources

Incidence of central serous chorioretinopathy (2011–2018): a nationwide population-based cohort study of Japan

British Journal of Ophthalmology, 2021
Aims The aim of this study was to elucidate the epidemiological background of central serous chorioretinopathy (CSC), including its incidence and treatment pattern.
Ai Kido, M. Miyake, H. Tamura, S. Hiragi, Takeshi Kimura, S. Ohtera, Ayako Takahashi, S. Ooto, K. Kawakami, T. Kuroda, A. Tsujikawa   +10 more
semanticscholar   +1 more source

SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY. [PDF]

, 2015
PURPOSE: To evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, for nonresolving central serous chorioretinopathy. METHODS: This is a prospective, randomized, double-blinded, placebo-controlled crossover study. Sixteen eyes of
Batista, R., Behar-Cohen, F., Bergin, C., Beydoun, T., Bousquet, E., Brandely, M.L., Chast, F., Couraud, B., Farman, N., Gaudric, A., Rothschild, P.R., Zhao, M.   +11 more
core   +4 more sources